Document Type

Tender Notice

Tender Summary

Tender Invited For Inj Nivolumab 240mg,inj Bevacizumab 800 Mg,tab Darolutamide 600mg,inj Cycloposphamide 500mg Plus 25 ##quantity: 337 ##

Action Deadline

29 Aug 2026